ACTA1 and lobular neoplasia: Additionally, while α-SMA is a widely accepted fibrosis marker in CKD, such as IgA nephropathy (IgAN), diabetic nephropathy (DN), and proliferative/non-proliferative glomerulonephritis, its cellular origins and pathogenic relevance in LN fibrosis remain to be fully established [13].